Foo J - Search Results

1

Stochastic dynamics of cancer initiation.

Foo J, Leder K, Michor F. Foo J, et al. Phys Biol. 2011 Feb;8(1):015002. doi: 10.1088/1478-3975/8/1/015002. Epub 2011 Feb 7. Phys Biol. 2011. PMID: 21301064 Free PMC article.

2

Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.

Foo J, Drummond MW, Clarkson B, Holyoake T, Michor F. Foo J, et al. PLoS Comput Biol. 2009 Sep;5(9):e1000503. doi: 10.1371/journal.pcbi.1000503. Epub 2009 Sep 11. PLoS Comput Biol. 2009. PMID: 19749982 Free PMC article.

3

Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies.

Foo J, Michor F. Foo J, et al. PLoS Comput Biol. 2009 Nov;5(11):e1000557. doi: 10.1371/journal.pcbi.1000557. Epub 2009 Nov 6. PLoS Comput Biol. 2009. PMID: 19893626 Free PMC article.

4

Evolution of resistance to anti-cancer therapy during general dosing schedules.

Foo J, Michor F. Foo J, et al. J Theor Biol. 2010 Mar 21;263(2):179-88. doi: 10.1016/j.jtbi.2009.11.022. Epub 2009 Dec 11. J Theor Biol. 2010. PMID: 20004211 Free PMC article.

5

Evolutionary dynamics of tumor progression with random fitness values.

Durrett R, Foo J, Leder K, Mayberry J, Michor F. Durrett R, et al. Among authors: foo j. Theor Popul Biol. 2010 Aug;78(1):54-66. doi: 10.1016/j.tpb.2010.05.001. Epub 2010 May 19. Theor Popul Biol. 2010. PMID: 20488197 Free PMC article.

6

Intratumor heterogeneity in evolutionary models of tumor progression.

Durrett R, Foo J, Leder K, Mayberry J, Michor F. Durrett R, et al. Among authors: foo j. Genetics. 2011 Jun;188(2):461-77. doi: 10.1534/genetics.110.125724. Epub 2011 Mar 15. Genetics. 2011. PMID: 21406679 Free PMC article.

7

Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling.

Chmielecki J, Foo J, Oxnard GR, Hutchinson K, Ohashi K, Somwar R, Wang L, Amato KR, Arcila M, Sos ML, Socci ND, Viale A, de Stanchina E, Ginsberg MS, Thomas RK, Kris MG, Inoue A, Ladanyi M, Miller VA, Michor F, Pao W. Chmielecki J, et al. Among authors: foo j. Sci Transl Med. 2011 Jul 6;3(90):90ra59. doi: 10.1126/scitranslmed.3002356. Sci Transl Med. 2011. PMID: 21734175 Free PMC article.

8

Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer.

Mumenthaler SM, Foo J, Leder K, Choi NC, Agus DB, Pao W, Mallick P, Michor F. Mumenthaler SM, et al. Among authors: foo j. Mol Pharm. 2011 Dec 5;8(6):2069-79. doi: 10.1021/mp200270v. Epub 2011 Oct 25. Mol Pharm. 2011. PMID: 21995722 Free PMC article.

9

Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia.

Leder K, Foo J, Skaggs B, Gorre M, Sawyers CL, Michor F. Leder K, et al. Among authors: foo j. PLoS One. 2011;6(11):e27682. doi: 10.1371/journal.pone.0027682. Epub 2011 Nov 28. PLoS One. 2011. PMID: 22140458 Free PMC article.

10

Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials.

Tang M, Foo J, Gönen M, Guilhot J, Mahon FX, Michor F. Tang M, et al. Among authors: foo j. Haematologica. 2012 Oct;97(10):1553-61. doi: 10.3324/haematol.2012.062844. Epub 2012 Mar 14. Haematologica. 2012. PMID: 22419579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

688 results

Search Page

Filters